| __timestamp | Soleno Therapeutics, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2242216 | 31354781 |
| Thursday, January 1, 2015 | 4536244 | 43445817 |
| Friday, January 1, 2016 | 5184803 | 66489820 |
| Sunday, January 1, 2017 | 3068742 | 96886134 |
| Monday, January 1, 2018 | 7178000 | 153793000 |
| Tuesday, January 1, 2019 | 16267000 | 148369000 |
| Wednesday, January 1, 2020 | 23191000 | 151934000 |
| Friday, January 1, 2021 | 21453000 | 198532000 |
| Saturday, January 1, 2022 | 15265000 | 112128000 |
| Sunday, January 1, 2023 | 25189000 | 76192000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, TG Therapeutics, Inc. and Soleno Therapeutics, Inc. have demonstrated contrasting investment strategies in R&D.
From 2014 to 2023, TG Therapeutics consistently outpaced Soleno Therapeutics, with an average annual R&D expenditure nearly nine times higher. Notably, in 2021, TG Therapeutics peaked with an investment of approximately $198 million, reflecting a 530% increase from 2014. In contrast, Soleno Therapeutics' R&D spending grew by 1,024% over the same period, reaching its highest in 2023 with $25 million.
These figures highlight TG Therapeutics' aggressive pursuit of innovation, while Soleno Therapeutics shows a steady, albeit smaller, commitment to R&D. This divergence in strategy underscores the varied approaches companies take in the biotech sector to drive growth and development.
R&D Insights: How Pfizer Inc. and TG Therapeutics, Inc. Allocate Funds
R&D Insights: How Bristol-Myers Squibb Company and TG Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Soleno Therapeutics, Inc.
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
Comparing Innovation Spending: TG Therapeutics, Inc. and Novavax, Inc.
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.